The core activity of Santhera Pharmaceuticals is the development and marketing of therapeutic solutions for rare and life-threatening diseases. The company focuses on researching and developing medications to improve the lives of patients with these diseases.
AI-generated
Offering
Products & services
Industry:Pharmaceutical Industry
✓ Offered5
Development and marketing of medicines
Development and marketing of medicines for rare and other diseases with high unmet medical need, with a focus on neuromuscular disorders.
Medicines for physicians and pharmacists
Information on products and pipeline for physicians, as well as details on product availability and ordering processes for pharmacies.
AGAMREE® (Vamorolon)
Approved medicine for the treatment of Duchenne muscular dystrophy; exclusively licensed worldwide and studied as an alternative to standard corticosteroids.
Research into neuromuscular disorders
Development of treatment options for neuromuscular diseases, in particular Duchenne muscular dystrophy and Becker muscular dystrophy.
Investor and media center
News, information and resources for investors and the media, including an investor toolbox, the news and media center, and the company calendar.
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.